BCAT1 expression was significantly and positively associated with TMB in four cancers, including COAD, brain lower grade glioma (LGG), SARC, and skin cutaneous melanoma (SKCM; Figure 3D). This evidence concerns the gene BCAT1 and cutaneous melanoma.